Healthcare provider profile · identity verified

Michael Sanson, M.D.

Internal Medicine · YPSILANTI, MI · NPI 1003817529

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Famotidine	Famotidine	735	263
Lisinopril	Lisinopril	681	192
Atorvastatin Calcium	Atorvastatin Calcium	629	192
Omeprazole	Omeprazole	466	136
Levothyroxine Sodium	Levothyroxine Sodium	465	125
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	370	46
Metformin Hcl	Metformin Hcl	349	101
Amlodipine Besylate	Amlodipine Besylate	323	96
Hydrochlorothiazide	Hydrochlorothiazide	270	77
Losartan Potassium	Losartan Potassium	269	77
Simvastatin	Simvastatin	256	68
Nortriptyline Hcl	Nortriptyline Hcl	245	79
Tamsulosin Hcl	Tamsulosin Hcl	233	78
Sertraline Hcl	Sertraline Hcl	218	70
Metoprolol Succinate	Metoprolol Succinate	212	66
Lorazepam	Lorazepam	203	67
Trazodone Hcl	Trazodone Hcl	191	67
Metoprolol Tartrate	Metoprolol Tartrate	155	46
Rosuvastatin Calcium	Rosuvastatin Calcium	152	44
Eliquis	Apixaban	139	34
Hydroxyzine Hcl	Hydroxyzine Hcl	103	50
Allopurinol	Allopurinol	101	28
Alprazolam	Alprazolam	100	22
Pantoprazole Sodium	Pantoprazole Sodium	97	30
Gabapentin	Gabapentin	93	25
Buspirone Hcl	Buspirone Hcl	89	36
Prednisone	Prednisone	89	54
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	88	50
Albuterol Sulfate Hfa	Albuterol Sulfate	87	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	81	21
Glipizide	Glipizide	76	29
Furosemide	Furosemide	72	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	19
Clopidogrel	Clopidogrel Bisulfate	68	22
Carvedilol	Carvedilol	67	18
Duloxetine Hcl	Duloxetine Hcl	66	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	62	14
Pravastatin Sodium	Pravastatin Sodium	62	17
Escitalopram Oxalate	Escitalopram Oxalate	59	19
Warfarin Sodium	Warfarin Sodium	59	15
Spironolactone	Spironolactone	58	22
Amitriptyline Hcl	Amitriptyline Hcl	56	14
Tramadol Hcl	Tramadol Hcl	54	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	13
Bupropion Hcl Sr	Bupropion Hcl	49	suppressed
Fluticasone Propionate	Fluticasone Propionate	49	18
Montelukast Sodium	Montelukast Sodium	48	14
Venlafaxine Hcl Er	Venlafaxine Hcl	48	13
Finasteride	Finasteride	46	16
Potassium Chloride	Potassium Chloride	44	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	42	26
Ibuprofen	Ibuprofen	42	16
Atenolol	Atenolol	39	13
Fluoxetine Hcl	Fluoxetine Hcl	37	12
Bupropion Xl	Bupropion Hcl	36	12
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	11
Alendronate Sodium	Alendronate Sodium	35	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	31
Ezetimibe	Ezetimibe	35	suppressed
Methocarbamol	Methocarbamol	34	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	32	suppressed
Azithromycin	Azithromycin	31	28
Jardiance	Empagliflozin	31	11
Nitroglycerin	Nitroglycerin	31	18
Donepezil Hcl	Donepezil Hcl	30	suppressed
Metformin Hcl Er	Metformin Hcl	30	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	30	26
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	26	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	20	suppressed
Bumetanide	Bumetanide	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Rizatriptan	Rizatriptan Benzoate	19	suppressed
Meloxicam	Meloxicam	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Cephalexin	Cephalexin	13	11
Naproxen	Naproxen	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Ozempic	Semaglutide	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Pulmicort Flexhaler	Budesonide	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Testosterone	Testosterone	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error